Immunocytokine, Use of an Immunocytokine, Pharmaceutical Composition, and Kit

BR112018076281B1Active Publication Date: 2026-11-10KYMBA LIMITED
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
BR112018076281
Authority / Receiving Office
BR · BR
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-04-06
Filing Date
2017-06-20
Publication Date
2026-11-10
Estimated Expiration
2037-06-20
Patent Text Reader

Abstract

The present invention relates to anti-PD-L1 antibodies, bispecific antibodies containing a domain specific to PD-L1, and immunocytokines comprising an anti-PD-L1 antibody fused to a cytokine, such as IL-2. The present invention also provides treatment methods, uses, and pharmaceutical compositions comprising the antibodies, bispecific antibodies, and immunocytokines.
Need to check novelty before this filing date? Find Prior Art